BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
12.51
+0.05 (0.40%)
At close: Dec 16, 2025, 4:00 PM EST
12.76
+0.25 (2.00%)
After-hours: Dec 16, 2025, 5:03 PM EST
BioAge Labs Stock Forecast
Stock Price Forecast
The 3 analysts that cover BioAge Labs stock have a consensus rating of "Buy" and an average price target of $11.33, which forecasts a -9.43% decrease in the stock price over the next year. The lowest target is $7.00 and the highest is $15.
Price Target: $11.33 (-9.43%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioAge Labs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 2 | 2 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $5 → $12 | Sell → Hold | Upgrades | $5 → $12 | -4.08% | Dec 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +19.90% | Oct 29, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $5 → $10 | Hold → Strong Buy | Upgrades | $5 → $10 | -20.06% | Oct 22, 2025 |
| Citigroup | Citigroup | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | -60.03% | Mar 24, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $5 | Sell | Initiates | $5 | -60.03% | Mar 7, 2025 |
Financial Forecast
Revenue This Year
7.20M
Revenue Next Year
2.94M
from 7.20M
Decreased by -59.17%
EPS This Year
-2.35
from -6.63
EPS Next Year
-2.97
from -2.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.4M | 8.8M | ||||
| Avg | 7.2M | 2.9M | ||||
| Low | 5.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 22.6% | ||||
| Avg | - | -59.2% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.16 | -2.78 | |
| Avg | -2.35 | -2.97 | |
| Low | -2.74 | -3.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.